正常肺功能年轻吸烟者的肺功能下降结构预测因素
年轻吸烟者QCT显示的功能性小气道病变、磨玻璃影、支气管血管束突出和小血管容积比均高于对照,且与FEV1下降更快相关,独立于症状影响。
要点
- 正常肺功能的年轻吸烟者CT已存在小气道病变等结构异常。
- 这些CT结构异常与FEV1下降更快独立相关。
- CT结构异常是COPD自然病程早期的疾病进展标志。
核心结论
- 正常肺功能的年轻吸烟者CT已存在放射学异常,且与FEV1下降相关,独立于症状影响。
- 结构异常出现在COPD自然病程早期,是疾病进展的标志。
研究设计与样本
- 招募431名当前吸烟者(中位年龄39岁,16包年)和67名从不吸烟对照,基时记录CAT、肺功能及QCT。
- FEV1下降率分析调整当前吸烟状态、年龄和性别。
主要发现
- 55.7%的年轻吸烟者CAT评分大于10,24.2%报告慢性支气管炎。
- 年轻吸烟者与对照在人口学和主观CT表现上无实质差异。
- 疾病概率定义的功能性小气道病变、磨玻璃影、支气管血管束突出及小血管容积与总肺血管容积比均高于对照。
- 上述QCT指标及更高CAT评分均与更快FEV1下降相关。
临床怎么用
- 对正常肺功能的年轻吸烟者,可考虑QCT评估早期结构异常以识别FEV1快速下降风险。
- CAT评分大于10提示症状负担,需关注与结构异常共同评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Chronic obstructive pulmonary disease (COPD) due to tobacco smoking commonly presents when extensive lung damage has occurred. Objectives: We hypothesized that structural change would be detected early in the natural history of COPD and would relate to loss of lung function with time. Methods: We recruited 431 current smokers (median age, 39 yr; 16 pack-years smoked) and recorded symptoms using the COPD Assessment Test (CAT), spirometry, and quantitative thoracic computed tomography (QCT) scans at study entry. These scan results were compared with those from 67 never-smoking control subjects. Three hundred sixty-eight participants were followed every six months with measurement of postbronchodilator spirometry for a median of 32 months. The rate of FEV1 decline, adjusted for current smoking status, age, and sex, was related to the initial QCT appearances and symptoms, measured using the CAT. Measurements and Main Results: There were no material differences in demography or subjective CT appearances between the young smokers and control subjects, but 55.7% of the former had CAT scores greater than 10, and 24.2% reported chronic bronchitis. QCT assessments of disease probability-defined functional small airway disease, ground-glass opacification, bronchovascular prominence, and ratio of small blood vessel volume to total pulmonary vessel volume were increased compared with control subjects and were all associated with a faster FEV1 decline, as was a higher CAT score. Conclusions: Radiological abnormalities on CT are already established in young smokers with normal lung function and are associated with FEV1 loss independently of the impact of symptoms. Structural abnormalities are present early in the natural history of COPD and are markers of disease progression. Clinical trial registered with www.clinicaltrials.gov (NCT03480347).
引用
- Ritchie AI, Donaldson GC, Hoffman EA, et al. Structural Predictors of Lung Function Decline in Young Smokers with Normal Spirometry. Am J Respir Crit Care Med. 2024. PMID: 38175920. doi:10.1164/rccm.202307-1203OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。